AVI Polymers (539288)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Very little about AVI Polymers passes my first test—I need to understand a business before I can value it. At ₹11.17, the entire company is priced at only ₹5 crore, barely above its book value of ₹9.87 per share. On the surface, a P/B of 1.13 offers a margin of safety, and ROCE of 19.42% is decent. But the other numbers do not add up. A P/E of 18.66 with a ₹5 crore market cap implies trailing net profit of roughly ₹0.27 crore; that would make ROE about 6%, not the reported 205.13%. The latest quarter allegedly shows ₹132 crore sales and ₹7 crore profit—that alone would justify a market cap many times this one. I cannot reconcile these figures, and when financial statements contradict themselves, I move on. The 1,000% profit growth sounds exciting, but sales growth is 0%. This is not a growing franchise; it is a margin rebound from a very low base. Specialty chemicals can be decent, but this is a microcap with no dividend, unknown promoter holding, and a 52-week range of ₹7.93 to ₹34.57. The stock has fallen from over ₹34 to ₹11, reminding me that small prices can become smaller. Piotroski’s 6/9 is mildly encouraging, but it does not overcome the governance and data red flags. I would demand far more audited history, cash flow statements, and a proven competitive moat before deploying capital. At best it is a speculative turnaround; at worst it is a value trap. In Graham’s language, price is what you pay, value is what you get—and here value cannot be estimated with the figures given.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer